Weight loss peptides like [tirzepatide](/product/tirzepatide) and [retatrutide](/product/retatrutide) deliver remarkable fat reduction. Phase 2 data on retatrutide showed up to 24.2 percent mean body-weight loss over 48 weeks; tirzepatide trials reported roughly 21 percent at the highest doses. Those numbers attract attention for good reason. But people who exercise regularly during a peptide protocol notice something less discussed in the headlines: workouts can feel harder, recovery takes longer, and the drive to train fades. The caloric deficit these peptides create is doing exactly what it should to body fat, yet the same deficit taxes the cellular fuel systems that power every sprint, lift, and set. That is where NAD+ enters the picture. Nicotinamide adenine dinucleotide sits at the crossroads of nearly every energy-producing pathway in the cell, from glycolysis to the mitochondrial electron transport chain. Supporting NAD+ levels during a peptide-driven cut may preserve workout quality, protect lean tissue signaling, and keep the metabolic machinery running at a pace that matches your training ambitions. ## Why exercise matters more, not less, during a peptide protocol Resistance training during caloric restriction is the single strongest lever for preserving lean mass. Published analyses of GLP-1 agonist trials show that roughly 25 percent of total weight lost can come from lean tissue when no structured exercise program is in place. Combining GLP-1 receptor agonist therapy with progressive resistance work and adequate protein intake shifts that ratio toward fat loss and away from muscle erosion. This is especially relevant for [retatrutide](/product/retatrutide), a triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. The glucagon-receptor component increases energy expenditure, which is a metabolic advantage for fat loss but also raises the bar for how much fuel the body demands. If the cellular supply chain cannot keep pace, performance drops. ## What NAD+ actually does inside working muscle NAD+ is required at multiple checkpoints in muscle energy production: **Glycolysis.** Every molecule of glucose broken down in the cytoplasm needs NAD+ to accept electrons at the glyceraldehyde-3-phosphate dehydrogenase step. Without adequate NAD+, anaerobic and aerobic glycolytic flux slows down, limiting the rate at which muscle can generate ATP from carbohydrate. **The citric acid cycle.** Three of the eight enzymatic steps in the Krebs cycle — isocitrate dehydrogenase, alpha-ketoglutarate dehydrogenase, and malate dehydrogenase — use NAD+ as an electron acceptor. A restricted NAD+ pool can become a rate-limiting factor for oxidative metabolism during sustained effort. **Electron transport chain.** NADH generated upstream donates electrons to Complex I, driving the proton gradient that ATP synthase uses to produce the bulk of cellular ATP. The ratio of NAD+ to NADH matters: a healthy ratio keeps the chain pulling electrons efficiently, while a collapsed ratio signals metabolic stress. **SIRT1-PGC-1-alpha signaling.** NAD+ is a required co-substrate for sirtuin-1, a deacetylase that activates PGC-1-alpha, the master regulator of mitochondrial biogenesis. When NAD+ is abundant, SIRT1 activity rises, promoting the creation of new mitochondria and improving the muscle's long-term oxidative capacity. Published data confirm that NAD+ supplementation upregulates SIRT activity and drives TFAM-mediated mitochondrial biogenesis through differential modulation of PGC-1-alpha and HIF-1-alpha. **DNA repair.** PARP enzymes consume NAD+ to fix exercise-induced DNA strand breaks. Heavy training increases PARP demand, which can drain NAD+ away from energy production if the total pool is already depleted by caloric restriction. In short, NAD+ is not a stimulant. It is a metabolic substrate that your cells spend every time they produce energy, repair damage, or build new mitochondria. ## The caloric-deficit problem: why NAD+ drops when you need it most Caloric restriction and the appetite suppression caused by GLP-1-based peptides reduce dietary intake of NAD+ precursors — tryptophan, niacin, nicotinamide riboside — that come from food. At the same time, the metabolic stress of training in a deficit increases NAD+ consumption via PARP activation and elevated SIRT1 demand. The result is a supply-demand mismatch: the body needs more NAD+ precisely when it is getting less of the raw materials to make it. Published research confirms this dynamic. A comprehensive review in Oxidative Medicine and Cellular Longevity showed that NAD+ levels can be modulated by fasting, caloric restriction, and exercise, and that low NAD+ availability impairs the mitochondrial electron transport that generates most of the ATP used during sustained physical work. Symptoms of this mismatch tend to be nonspecific: persistent fatigue that does not improve with rest, longer recovery between training sessions, reduced work capacity at submaximal loads, and a subjective sense that effort feels disproportionate to output. These are often attributed to "overtraining" or "not eating enough," but the underlying mechanism may be a cellular energy bottleneck at the NAD+ level. ## Practical protocol: stacking NAD+ with weight loss peptides The goal is to maintain NAD+ availability high enough to support training adaptations without interfering with the fat-loss benefits of the peptide. Here is how to structure it. ### Product selection [NAD+](/product/nad) injectable vials provide a direct, bioavailable form of the coenzyme. For those who prefer a more convenient delivery method, the [NAD+ Pen](/product/nad-pen) offers pre-measured dosing in a portable format that simplifies daily administration. ### Timing around training Administer NAD+ on training days, ideally 30 to 60 minutes before the session. This positions peak bioavailability during the window when glycolytic and oxidative demand is highest. On rest days, a maintenance dose supports recovery-phase processes like SIRT1-mediated mitochondrial biogenesis and PARP-driven DNA repair. ### Coordination with peptide dosing [Tirzepatide](/product/tirzepatide) is typically administered once weekly. [Retatrutide](/product/retatrutide) follows a similar weekly schedule. NAD+ operates on a different metabolic timeline — its half-life in plasma is measured in hours, not days — so there is no pharmacokinetic conflict. Administer the peptide on its scheduled day. Use NAD+ as a daily or training-day adjunct without altering the peptide schedule. ### Supporting inputs NAD+ supplementation works within a system, not in isolation. During a peptide-induced caloric deficit, prioritize: - **Protein intake:** 1.6 to 2.2 grams per kilogram of body weight per day. This supports muscle protein synthesis and provides tryptophan, a dietary NAD+ precursor. - **Resistance training:** at least three sessions per week, emphasizing compound movements. This is the primary driver of lean-mass preservation during weight loss. - **Sleep:** seven to nine hours. NAD+-dependent circadian clock proteins (CLOCK and BMAL1) regulate metabolic rhythms that affect both recovery and fat oxidation. - **Hydration and electrolytes:** GLP-1 agonists can reduce fluid intake through appetite suppression. Maintain deliberate hydration to support blood volume and nutrient transport to working muscle. ## Training adjustments while on weight loss peptides Running a peptide protocol is not the time to chase personal records on every lift. The caloric deficit changes the recovery landscape. Practical adjustments include: **Reduce volume before intensity.** Maintain the heaviest working sets but cut total volume by 20 to 30 percent. This preserves the mechanical tension signal that tells muscle to stay while reducing the total recovery debt. **Prioritize compound movements.** Squats, deadlifts, presses, rows, and pull-ups recruit more total muscle mass per unit of time. In a deficit, efficiency matters more than variety. **Monitor recovery markers.** Track resting heart rate, grip strength, and subjective readiness. If recovery metrics trend downward over two or more weeks, reduce training frequency before reducing NAD+ support. **Use periodized cardio.** Moderate-intensity steady-state cardio (zone 2) is metabolically efficient and promotes fat oxidation without excessive glycogen depletion. Limit high-intensity interval training to two sessions per week during the active weight-loss phase, as HIIT places high demands on both glycolytic NAD+ turnover and post-exercise PARP activity. ## What the research shows about combined NAD+ and exercise interventions Animal data consistently support the synergy. A 2025 study on aged mice demonstrated that the combined intervention of NMN supplementation and aerobic exercise significantly enhanced systemic energy metabolism, measured by increased VO2, elevated energy expenditure, and greater locomotor activity. Human translation is nuanced. A review in Sports Medicine noted that NAD+ therapeutics have not yet shown performance benefits in healthy, well-nourished athletes. However, the review emphasized that benefits appear when NAD+ deficiency is present — a condition more likely during the caloric restriction induced by weight loss peptides. Patients with diagnosed mitochondrial myopathy and confirmed NAD+ deficiency who received supplementation showed improved intramuscular NAD+ abundance, mitochondrial biogenesis, respiratory chain activity, and muscle performance. The practical takeaway: the less you eat, the more relevant NAD+ support becomes. A person maintaining body weight on adequate calories is unlikely to have a functionally limiting NAD+ shortfall. A person running a 500-to-1000-calorie daily deficit under tirzepatide while training four days a week faces a different metabolic reality. ## Monitoring your response Subjective and objective markers hel...